跳至主要内容
临床试验/PACTR202310817339585
PACTR202310817339585尚未招募Unknown

se of continuous glucose monitoring devices among people living with type 1 diabetes in South Africa: A three-arm pragmatic randomized study on the effectiveness, feasibility, acceptability, and cost.

Foundation for Innovative New Diagnostics0 个研究点目标入组 246 人开始时间: 2023年6月19日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
246

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Year(s) 至 12 Year(s)(—)
性别
All

入选标准

  • Recipients of Care eligibility criteria:
  • People living with type 1 diabetes with current HbA1c levels =10% / >86mmol/mol (and for at least 2 measurements over 18 months) attending for diabetes care at the 3 sites.
  • Health care providers eligibility criteria:
  • Healthcare providers at the study sites engaged in diabetes care provision related to the study

排除标准

  • Recipients of Care exclusion criteria:
  • People living with type 1 diabetes under 4 years of age.
  • People diagnosed with type 1 diabetes within the last 2 years.
  • People who have used a CGM in the last 6 months prior to enrollment.
  • People who anticipate that they would have access to a CGM through means outside this study during the duration of the study (15 months).
  • People living with type 2 diabetes.
  • Known pregnancy at time of enrolment.

研究者

相似试验